ROLE SUMMARY
Reporting to the Rare Disease Research Unit (RDRU) Head of Portfolio, Strategy & Operations, the Chief of Staff (CoS) is a key member of the RDRU Leadership Team (LT) and is responsible for driving daytoday operational support for the Chief Scientific Officer (CSO), including the CSO's key interactions, meetings, & presentations. He/she operates as a senior level advisor and strategic sounding board to the CSO across a breadth of strategic, operational and communications initiatives/activities, deliverables and special projects. The CoS also supports initiatives related to continuous improvement of RDRU culture and colleague engagement and will lead a group of RDRU Operations staff. The CoS will enable the CSO to ensure effective messaging to internal and external stakeholders.
ROLE RESPONSIBILITIES
* Drive day-to-day business and operational support for the CSOs key interactions, meetings and presentations to enhance organizational efficiency with key partners and stakeholders.
* Member of RDRU LT with responsibilities for planning, meeting coordination, agenda management, minutes, action tracking and close out of key complex meetings for CSO.
* Interface with and engage key stakeholders (e.g., Worldwide Research, Development & Medical (WRDM)-LT members, WRDM-LT Chiefs of Staff and other WRDM members, RDRU leaders and members, RD Category leaders) to manage and coordinate operational and planning needs on behalf of the CSO.
* Leveraging a deep scientific background, participate in / lead selected planning efforts & initiatives in partnership with the Head of Portfolio, Strategy and Operations. This will facilitate alignment, coordination and implementation of RDRU internal and external strategy, priorities and related communications.
* Develop strong understanding of our R&D strategy, pipeline and capabilities, and actively leverage this knowledge to inform priorities for the CSO.
* Support ideation and coordination of RDRU semester goals and partner with RDRU LT to advance goals.
* Represent the CSO and RDRU organization throughout the WRDM enterprise, on WRDM committees and other corporate-wide committees as appropriate, including analyst and investor prep teams, governance and planning committees, and corporate calendar planning.
* Ensure requests for action and information from WRDM leadership, Pfizer headquarters and external constituents are furnished in a timely, coordinated manner; effectively manage all correspondence and communications involving both routine and complex matters.
* Manage and track commitments by the CSO; execute follow-up activities as appropriate to ensure RDRU LT and staff implementation.
* Manages and executes critical meetings, events, commitments and communications to ensure input is provided, stakeholders are informed, and successful outcomes are achieved.
* Support the compilation of strategic documents and presentations (e.g., analyst briefings, etc.) in collaboration with other partners.
* Play a key role in the development and tracking of WRDM and RDRU goals and initiatives by working with key partners to drive an effective and efficient process for RDRU
* Help address and coordinate requests from various Pfizer stakeholders, e.g., WRDM LT, RU members, Global Product Development (GPD) members, etc.
* Manage and oversee, in partnership with Head of Portfolio, Strategy & Operations, select RDRU-related activities (e.g., External Advisor meetings, LT off sites, site visits, Townhalls)
* Manage and oversee end-to-end planning of RDRU LT and Extended LT meetings.
* Partner with Communications team to support planning and management of internal and external communications needs of the CSO (for example: Town Halls, site visits, external appearances, press releases, media coverage, etc.).
* Ensure preparation of talking points for CSO communications, as well as support for leader communications regarding change initiatives and process improvements.
* Partner with HR to design and lead various development opportunities for groups, teams, and individuals.
* Help navigate broader WRDM and Pfizer organization to quickly connect colleagues to appropriate individuals or resources, as needed.
* Provide advice and guidance to the CSO pertaining to internal events as well as the external environment.
* Be an objective sounding board.
* Partnering with finance colleagues, is responsible for managing the RDRU Operating expense budget.
* Partnering with Business Development and Legal, is responsible for contracting and delivering value from RDRU Research collaborations, ensuring compliance to local and global policies.
* Ensures compliance of laboratories and scientists with legal requirements and corporate policies and safe working practices.
* Ensures compliance to local and global policies, e.g. Sunshine Act and Foreign Corrupt Practices Act.
* Eliminate barriers and silos that inhibit collaboration across departments and line functions and foster a culture of open collaboration, communication and transparency.
* Lead processes to effectively, rigorously and accurately review and develop RDRU talent. Proactively address development needs and make difficult decisions when appropriate.
BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
* Bachelors degree (advanced degree a plus e.g. MBA, etc.); PhD in a life science discipline preferred.
* 8-10 years of experience in the Biotech/Pharmaceutical Industry or equivalent.
* The successful candidate will be a well-organized, creative, independent, self-motivated individual with exceptional written and oral communication skills.
* Must have a scientific background and strong interest in learning more about our R&D strategy, pipeline, key assets and capabilities.
PREFERRED QUALIFICATIONS
* R&D Operational and Business Line knowledge/experience a plus.
* Experience with providing executive level support, and development of business and visibility platforms for senior executives.
* Demonstrate Pfizer business and scientific acumen; strong project management and multi-tasking skills; ability to respond to tight timelines; proven capability to interact with all levels of the organization in a professional and discreet manner.
* Robust understanding of biopharmaceutical industry, R&D processes, and the external and internal business environment.
* Familiarity with the Pfizer organization (or other relevant organization), particularly R&D/Business Units/Enabling Functions.
* Demonstrate a fundamental understanding of the pharmaceutical/biotech business and R&D/clinical environment with experience from early discovery through clinical development of therapeutic candidates.
* Proven ability in managing day-to-day Planning and Communication activities.
* Experienced in communicating and interacting with senior internal and external stakeholders.
* Strong interpersonal skills, organizational maturity and ability to develop a network of trusted relationships with peers and other stakeholders.
* Possess a high energy level, sense of urgency, creativity, decisiveness, ability to work hard and well under pressure.
* Demonstrated ability to influence without hierarchy across the organization.
* Commitment to leadership, diversity and talent development.
* Ability to work effectively across interfaces and to navigate a complex matrixed organization.
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
* Occasional travel to RDRU sites in Durham, NC, and Nice, France, may be required.
* Travel to HQ (New York) as necessary to support CSO-associated activities.
Other Job Details:
* Last Date to Apply for Job: March 31, 2021
* Eligible for Relocation Package: YES
* Eligible for Employee Referral Bonus: YES
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Support Services
LI-PFE
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.